William Blair has initiated coverage on Sotera Health Co (SHC) with an Outperform rating, marking the firm's first assessment of the company. This decision reflects an analysis of Sotera's business dynamics and growth prospects within the life sciences tools and services industry.
Sotera Health, headquartered in Broadview Heights, Ohio, specializes in mission-critical sterilization, lab testing, and advisory services for the medical device and pharmaceutical sectors. The company operates through its segments: Sterigenics, Nordion, and Nelson Labs. As of November 25, 2025, Sotera holds a market capitalization of $4.8 billion, with a trailing P/E ratio of 86.01 and an EPS of $0.19.
Upcoming earnings reports are scheduled for April 29, 2026, and August 6, 2026, with expected EPS of $0.18 and $0.23, respectively. Recent earnings performance has shown positive surprises, including a Q3 2025 EPS of $0.26, exceeding estimates by 17.8%.
Analyst ratings serve as professional opinions based on extensive research and financial modeling. While they can provide valuable insights, they are based on assumptions that may not always materialize. Investors are encouraged to consider a range of factors, including company fundamentals and market conditions, when making decisions. Notably, analyst ratings can evolve as new information becomes available, with varying opinions across different analysts.